Clinical Trials Directory

Trials / Terminated

TerminatedNCT00170313

CORE: Study to Evaluate the Conducted AF-Response-Algorithm in Patients Suffering From Heart Failure and Atrial Fibrillation

Conducted AF-Response Study (Study to Evaluate the Conducted AF-Response-Algorithm in Patients Suffering From Heart Failure and Atrial Fibrillation Treated With InSync III Marquis)

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Medtronic Cardiac Rhythm and Heart Failure · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The Medtronic InSync III Marquis Cardiac Resynchronization Therapy Defibrillator (CRT-D)-System (implantable cardioverter-defibrillator with biventricular stimulation for cardiac resynchronization) is equipped with the "Conducted-Atrial Fibrillation (AF)-Response-Algorithm (CAFR)". This algorithm is designed to maximize biventricular stimulation and thus the amount of cardiac resynchronization when atrial fibrillation occurs. The goal of the study is the evaluation of the effect of the CAFR in CRT-patients suffering from atrial fibrillation by quantification of the increase of biventricular pacing during atrial fibrillation caused by CAFR as well as the influence of the CAFR on the ventricular heart rate.

Conditions

Interventions

TypeNameDescription
DEVICEConducted AF-Response Algorithm (CAFR) OnAlgorithm will be enabled.
DEVICEConducted AF-Response Algorithm (CAFR) OffAlgorithm will be disabled.

Timeline

Start date
2003-12-01
Completion
2007-01-01
First posted
2005-09-15
Last updated
2025-07-03

Locations

7 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT00170313. Inclusion in this directory is not an endorsement.